Takara Bio Inc
TSE:4974
Takara Bio Inc
TSE:4974
Price:
1 092 JPY
0.83%
Market Closed
Updated:
May 21, 2024
Takara Bio Inc
Income from Continuing Operations
|
Takara Bio Inc
Income from Continuing Operations Peer Comparison
Comparables:
2160
4587
2929
J
7774
S
4599
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takara Bio Inc
TSE:4974
|
Income from Continuing Operations
¥1.5B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
|
GNI Group Ltd
TSE:2160
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
91%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Income from Continuing Operations
¥3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Income from Continuing Operations
¥4.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
40%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Income from Continuing Operations
¥143.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
StemRIM Inc
TSE:4599
|
Income from Continuing Operations
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Income from Continuing Operations?
Income from Continuing Operations
1.5B
JPY
1.5B
JPY
Based on the financial report for Mar 31, 2024, Takara Bio Inc's Income from Continuing Operations amounts to 1.5B JPY.
What is Takara Bio Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%
0%
Over the last year, the Income from Continuing Operations growth was -91%. The average annual Income from Continuing Operations growth rates for Takara Bio Inc have been -46% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
